Responses

Download PDFPDF

Tobacco endgame goals and measures in Europe: current status and future directions
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    The tobacco endgame … a reassuring smoke screen?

    NOT PEER REVIEWED

    How can the special communication promoting the 2040 Tobacco- Free Generation goal of the European Union (1) flew in the face of the warning “we are still waiting for the European political commitment to quit tobacco.”(2)

    Firstly, the communication of the goal by the Commission in 2021 remains empty words yet. Of note, the most recent directive for tobacco control, proposed by the Commission in 2012, only became applicable in 2016.

    Secondly, promises only bind those who believe in them. Europe will be the only WHO region not to reach the global non-communicable diseases target by 2025,(2) Could the new goal be achievable : a) when smoking prevalence only decreased form 24% in 2010 to 19% in 2020;(3) b) when the reduction in nicotine content, a silver bullet vs young uptake, is totally ignored and when responses about measures were only obtained from 19 of 27 EU Member states,(1) questioning their implication.(1) As a French, I want to stress that in 2019, France was among the six countries globally with a smoking prevalence above 33% among people aged 15-24.(4) Its recent plan raises cigarette retail prices to €12 in 2025, and to €13 in 2026, is less than the 10% threshold for a 4% impact on sales, not to account the present high inflation rates that seriously blunt the true increase. This deliberate strategy from experts in Laffer curve accounts for the low price elasticity of a highly addictive substance in order to increase reven...

    Show More
    Conflict of Interest:
    None declared.